Table 2.
Adverse events, regardless of their relationship to the study drug.
Adverse Event | All Grades | % | Grade 3–4 | % |
---|---|---|---|---|
Fatigue | 16 | 51.6% | ||
LFT elevations | 15 | 48.4% | 2 | 6.5% |
Nausea | 12 | 38.7% | ||
Anorexia | 8 | 25.8% | ||
Constipation | 6 | 19.4% | ||
Diarrhea | 5 | 16.1% | ||
Alopecia | 4 | 12.9% | ||
Dehydration | 4 | 12.9% | 2 | 6.5% |
Leukopenia | 3 | 9.7% | 2 | 6.5% |
Neutropenia | 3 | 9.7% | 3 | 9.7% |
Thrombocytopenia | 3 | 9.7% | 2 | 6.5% |
Creatinine elevation | 3 | 9.7% | ||
Headache | 3 | 9.7% | ||
Bone pain | 3 | 9.7% | 2 | 6.5% |
Anemia | 2 | 6.5% | 2 | 6.5% |